LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Robotic Platform Enables More Accurate Diagnosis of Cancer Cells

By LabMedica International staff writers
Posted on 25 Oct 2023

For more than a century, the field of histology, which falls under pathology and focuses on changes in tissue, has relied on an old-school method. This involves slicing tissue samples into extremely thin sections—each about seven times thinner than a human hair—and then examining them for any abnormal changes under a microscope. The downside of this traditional technique is that it leads to misdiagnosis in about one out of every six people, often missing cancer cells. Now, scientists have integrated biomedical technology with mechanical engineering to create a robotic system that not only diagnoses cancer more precisely but also offers three-dimensional insights into the spatial arrangement of cells.

Researchers from ETH Zurich (Zurich, Switzerland) and the University of Zurich (Zurich, Switzerland) are working on this robotic platform designed to improve the accuracy of cancer diagnosis by rapidly quantifying tissue samples in their entirety. The procedure involves four stages. First, the tissue sample is automatically made transparent. Second, any unusual cells are quickly stained or colored. The third phase consists of generating a 3D image that maps out the cancer cells; the technology for this is already available. The last phase involves analyzing the tissue using 3D imaging software and training algorithms. This novel approach eliminates the need for labor-intensive preparation and slicing of tissue samples; instead, the entire tissue sample—like a lymph node—is preserved and fully examined. The 3D digital images showing the marked cells can be accessed online whenever needed.


Image: A tissue sample, for example a lymph node, is only 5–10 mm in size (Photo courtesy of ETH Zurich)
Image: A tissue sample, for example a lymph node, is only 5–10 mm in size (Photo courtesy of ETH Zurich)

Currently, the robot prototype is functional in the lab and can maneuver samples as required. However, it's not yet completely market-ready. While the team can provide preliminary services like automatically rendering sent-in tissue samples transparent and generating labeled 3D images swiftly, the software still needs fine-tuning. The researchers aim to commercialize this robotic system, offering research laboratories and healthcare facilities a dependable and effective tool that could revolutionize the way cancer diagnosis is conducted in the digital age.

Related Links:
ETH Zurich 
University of Zurich 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Gold Member
Hematology Analyzer
Medonic M32B

Latest Pathology News

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer
25 Oct 2023  |   Pathology

Saliva Test to Enable Early Detection of Diabetes and Obesity
25 Oct 2023  |   Pathology

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery
25 Oct 2023  |   Pathology